Literature DB >> 2143199

Variable expression of 5 alpha-reductase deficiency: presentation with male phenotype in a child of Greek origin.

T O Carpenter1, J Imperato-McGinley, S D Boulware, R M Weiss, C Shackleton, J E Griffin, J D Wilson.   

Abstract

A male infant with perineal hypospadias and a small phallus bound in chordee is described. Biochemical investigation at age 9 months after hCG stimulation revealed a testosterone to dihydrotestosterone (DHT) ratio of 40, a markedly elevated value suggestive of deficient steroid 5 alpha-reductase activity. The diagnosis of 5 alpha-reductase deficiency was confirmed by elevated urinary 5 beta/5 alpha-steroid metabolite ratios and demonstration of defective 5 alpha-reductase activity in cultured fibroblasts from the patient's scrotum and foreskin. Application of DHT cream to the patient's abdomen raised circulating levels of DHT to the adult male range. Two courses of DHT given nightly for 3 and 4 months resulted in phallic enlargement. Surgical release of the chordee and hypospadias repair have resulted in normal male appearance of the genitalia. This case illustrates the heterogeneity of the 5 alpha-reductase deficiency phenotype.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143199     DOI: 10.1210/jcem-71-2-318

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  A novel mutation of 5alpha-steroid reductase 2 deficiency (CD 65 ALA-PRO) with severe virilization defect in a Turkish family and difficulty in gender assignment.

Authors:  Senay Savas Erdeve; Zehra Aycan; Merih Berberoglu; Zeynep Siklar; Bulent Hacihamdioglu; Kadir Sipahi; Nejat Akar; Gonul Ocal
Journal:  Eur J Pediatr       Date:  2010-02-24       Impact factor: 3.183

Review 2.  Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels.

Authors:  Ronald S Swerdloff; Robert E Dudley; Stephanie T Page; Christina Wang; Wael A Salameh
Journal:  Endocr Rev       Date:  2017-06-01       Impact factor: 19.871

3.  Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat.

Authors:  Christopher Grunseich; Ilona R Kats; Laura C Bott; Carlo Rinaldi; Angela Kokkinis; Derrick Fox; Ke-Lian Chen; Alice B Schindler; Ami K Mankodi; Joseph A Shrader; Daniel P Schwartz; Tanya J Lehky; Chia-Ying Liu; Kenneth H Fischbeck
Journal:  Neuromuscul Disord       Date:  2014-07-03       Impact factor: 4.296

Review 4.  The effect of 5α-reductase-2 deficiency on human fertility.

Authors:  Hey-Joo Kang; Julianne Imperato-McGinley; Yuan-Shan Zhu; Zev Rosenwaks
Journal:  Fertil Steril       Date:  2014-01-08       Impact factor: 7.329

5.  Molecular genetic analysis and human chorionic gonadotropin stimulation tests in the diagnosis of prepubertal patients with partial 5 alpha-reductase deficiency.

Authors:  O Hiort; H Willenbring; N Albers; W Hecker; J Engert; L Dibbelt; G H Sinnecker
Journal:  Eur J Pediatr       Date:  1996-06       Impact factor: 3.183

6.  5 alpha-reductase deficiency in patients with micropenis.

Authors:  Y Z Gad; H Nasr; I Mazen; N Salah; R el-Ridi
Journal:  J Inherit Metab Dis       Date:  1997-03       Impact factor: 4.982

7.  Molecular genetics of steroid 5 alpha-reductase 2 deficiency.

Authors:  A E Thigpen; D L Davis; A Milatovich; B B Mendonca; J Imperato-McGinley; J E Griffin; U Francke; J D Wilson; D W Russell
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  5 α-reductase type 2 deficiency: response to dihydrotestosterone gel.

Authors:  Madhavarao Vupputuri; Madhurima Kandepu; Harikishore Reddy Devireddy
Journal:  Indian J Pediatr       Date:  2013-05-24       Impact factor: 1.967

9.  5α-Reductase Isozymes in the Prostate.

Authors:  Yuan-Shan Zhu; Guang-Huan Sun
Journal:  J Med Sci       Date:  2005

10.  Male pseudohermaphroditism due to primary 5 alpha-reductase deficiency: variation in gender identity reversal in seven Mexican patients from five different pedigrees.

Authors:  J P Méndez; A Ulloa-Aguirre; J Imperato-McGinley; A Brugmann; M Delfin; B Chávez; C Shackleton; S Kofman-Alfaro; G Pérez-Palacios
Journal:  J Endocrinol Invest       Date:  1995-03       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.